C4 Therapeutics, Inc. (CCCC) Stock buybacks 2019–2025
C4 Therapeutics, Inc. (CCCC) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$193,000FY2025 · since FY2019: $30,000 → $193,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $193,000 | -0.5% |
| FY2024 | $194,000 | +76.4% |
| FY2023 | $110,000 | — |
| FY2022 | $0 | — |
| FY2020 | $194,000 | +546.7% |
| FY2019 | $30,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice